New Insights into How Acetaminophen Alleviates Pain: A Breakthrough Study

A groundbreaking study reveals that acetaminophen (Tylenol) works not only in the brain but also directly on peripheral nerves by producing a compound that blocks pain signals, opening new avenues for safer pain relief medications.
Recent research from the Hebrew University of Jerusalem has shed new light on the mechanisms behind acetaminophen's pain-relieving effects. Published in the Proceedings of the National Academy of Sciences, this study uncovers a peripheral pathway through which the drug operates, challenging long-standing beliefs.
Traditionally, scientists believed that acetaminophen (also known as paracetamol, Tylenol, or Panadol) worked exclusively within the brain and spinal cord to reduce pain. However, the new findings reveal that the drug also acts directly on nerves outside the central nervous system, specifically targeting pain-sensing nerve endings.
The key to this process is a substance called AM404, which the body produces after administering acetaminophen. The research team demonstrated that AM404 is generated locally in nerve endings and functions by blocking sodium channels—crucial pathways for transmitting pain signals. This blockade prevents pain signals from being sent to the brain, effectively reducing pain perception at its source.
Lead researcher Professor Alexander Binshtok explained, "This is the first time we've shown that AM404 works directly on peripheral nerves. It significantly alters our understanding of how acetaminophen fights pain."
This discovery opens new doors for developing innovative pain treatments. By targeting only the nerves involved in pain transmission, future medications inspired by this mechanism could offer effective relief with fewer side effects, such as numbness or muscle weakness, commonly associated with traditional local anesthetics.
Professor Avi Priel emphasized the potential impact, stating, "If we can design drugs based on AM404, we might achieve highly effective pain relief that is safer and more precise, minimizing adverse effects."
Overall, this breakthrough enhances our understanding of analgesic mechanisms and paves the way for next-generation pain therapies that are both effective and safer for patients.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Caregivers Express Greater Satisfaction with Specialized Dementia Care Programs Compared to Standard Care
A recent study finds that caregivers of dementia patients are more satisfied with specialized care programs than with usual care, highlighting the importance of caregiver experience in dementia support strategies.
Innovative AI-Driven, Affordable Blood Tests for Early Alzheimer’s Detection
A team of scientists at the University of Liverpool has developed low-cost, AI-powered blood tests capable of detecting early signs of Alzheimer's disease, promising broader access to early diagnosis and treatment.
Pets May Contribute to Rising Antibiotic Resistance, Researchers Warn
Recent research reveals that antibiotic use in household pets like dogs and cats may be fueling the rise of antibiotic-resistant bacteria, highlighting the need for improved stewardship in veterinary medicine.
Stuttering Is More Than Just a Speech Disorder: A New Neurological Perspective
New research from the University of Mississippi reveals that stuttering is a complex neurological condition involving systemic factors like gut health and genetic mutations, opening pathways for targeted treatments beyond traditional speech therapy.